Novo Nordisk CEO Faces Angry Shareholders

Novo Nordisk's CEO, Lars Rebien Sorensen, will appear before shareholders at the company's annual general meeting this Thursday, following a recent change in the board of directors. He is expected to face tough criticism regarding the board upheaval and its implications. This event signals potential investor concerns and a challenge for the company's leadership.

Summarized from the sources above. Read the originals for the full story.